Drug Approval | July 02, 2022
Ascentage Pharma gets IND clearance by the US FDA for novel EED Inhibitor APG-5918
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
This multicenter, open-label Phase I study is designed to assess the safety and tolerability
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
By applying digital technologies, pharma companies can significantly improve their operational and decision-making capabilities
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
Bringing next-gen cannabinoid therapeutics to cancer patients
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
The new program includes upstream and downstream process development and large-scale GMP production.
_256_384.png)
Thermo Scientific Direct Mass Technology mode augments Thermo Scientific Q Exactive UHMR Hybrid Quadrupole-Orbitrap mass spectrometers with charge detection capabilities
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
Subscribe To Our Newsletter & Stay Updated
